Specify a stock or a cryptocurrency in the search bar to get a summary
Arjo AB (publ)
A39Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden. Address: Hans Michelsensgatan 10, Malmö, Sweden, 201 20
Analytics
WallStreet Target Price
568.19 SEKP/E ratio
19.3946Dividend Yield
2.46 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures A39
Dividend Analytics A39
Dividend growth over 5 years
70 %Continuous growth
1 yearPayout Ratio 5 years average
54 %Dividend History A39
Stock Valuation A39
Financials A39
Results | 2019 | Dynamics |